Identification of complement receptor one (CR1) polymorphisms in West Africa

被引:0
|
作者
JM Moulds
L Kassambara
JJ Middleton
M Baby
I Sagara
A Guindo
S Coulibaly
D Yalcouye
DA Diallo
L Miller
O Doumbo
机构
[1] University of Texas-Houston Medical School,
[2] University of Mali,undefined
[3] National Institute of Allergy and Infectious Disease,undefined
[4] NIH,undefined
来源
Genes & Immunity | 2000年 / 1卷
关键词
malaria; blood groups; complement receptors;
D O I
暂无
中图分类号
学科分类号
摘要
Complement receptor one (CR1) is a ligand for the rosetting of Plasmodium falciparum infected red cells with uninfected cells. Since CR1 exhibits three known polymorphisms, we studied European-Americans (n = 112) and African-Americans (n = 330) and Malians (n = 158) to determine if genetic differences existed in an area endemic for malaria that could offer a survival advantage. The frequencies of Knops blood group phenotypes McC(b+) and Sl(a−) were greatly increased in Africans vs Europeans. Although the frequency of McC(b+) was similar between Africans from the USA or Mali, the Sl(a−) phenotype was significantly higher in Mali (39% vs 65%, respectively). There was an increased frequency of the largest size (250 kD) of CR1 in Mali, but this did not differ significantly from the USA (P = 0.09). Both cohorts of Africans had higher expression of red cell CR1 than European-Americans but this showed little difference between the USA and Mali groups. Thus, the most important CR1 polymorphism relevant to rosetting of malaria infected cells appears to be the Knops blood group.
引用
收藏
页码:325 / 329
页数:4
相关论文
共 50 条
  • [41] Protection from collagen-induced arthritis by complement receptor CR2/CR1 deficiency
    Kuhn, KA
    Holers, VM
    FASEB JOURNAL, 2005, 19 (04): : A913 - A913
  • [42] Protection from collagen-induced arthritis by complement receptor CR2/CR1 deficiency
    Kuhn, KA
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 261 - 261
  • [43] Protection from collagen-induced arthritis by complement receptor CR2/CR1 deficiency
    Kuhn, KA
    Holers, VM
    CLINICAL IMMUNOLOGY, 2005, 115 : S103 - S104
  • [44] Evolution of the Sl(a) region of complement receptor 1 (CR1) in primates from old and new worlds
    Donvito, B
    Kisserli, A
    Gimenez, A
    Godin, N
    Mahmoud, W
    Libyh, MT
    Duret, V
    Reveil, B
    Tabary, T
    Cohen, JHM
    MOLECULAR IMMUNOLOGY, 2006, 43 (1-2) : 147 - 147
  • [45] Indels and imperfect duplication have driven the evolution of human complement receptor 1 (CR1) and CR1-like from their precursor CR1 alpha:: Importance of functional sets
    McLure, CA
    Williamson, JF
    Stewart, BJ
    Keating, PJ
    Dawkins, RL
    HUMAN IMMUNOLOGY, 2005, 66 (03) : 258 - 273
  • [46] Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease
    Mahmoudi, Rachid
    Feldman, Sarah
    Kisserli, Aymric
    Duret, Valerie
    Tabary, Thierry
    Bertholon, Laurie-Anne
    Badr, Sarah
    Nonnonhou, Vignon
    Cesar, Aude
    Neuraz, Antoine
    Novella, Jean Luc
    Cohen, Jacques Henri Max
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [47] Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus
    Arora, V
    Verma, J
    Dutta, R
    Marwah, V
    Kumar, A
    Das, N
    MOLECULAR IMMUNOLOGY, 2004, 41 (04) : 449 - 456
  • [48] Complement receptor type 1 (CR1, CD35) inhibits Fc receptor mediated degranulation.
    Wu, J
    Li, X
    McDuffie, D
    Kimberly, RP
    Edberg, JC
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S472 - S472
  • [49] An erythrocytary decrease in type 1 complement receptor (CR1) during pregnancy is exacerbated by Plasmodium infection
    Aldebert, D.
    Hatim, B.
    Sire, J.
    Donvito, B.
    Cohen, J.
    Moreau, J.
    Jambou, R.
    ACTA TROPICA, 2005, 95 : S438 - S438
  • [50] Protection from collagen-induced arthritis by complement receptor CR2/CR1 deficiency
    Kuhn, Kristine A.
    Holers, V. Michael
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 199 - 199